9.48 USD
↗ 0.13 (1.39%)LIVE (AS OF 11:53 AM EST)
MiNK Therapeutics, Inc. Common Stock (INKT) trades at $9.48 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (67.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, INKT trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 16, 2026.